CalciMedica is trading $1.48, down 10.06%, with no company-specific catalyst identified.
- No November 2 company-specific announcement appeared on CalciMedica’s investor-relations press-release page; its latest listed release is dated September 8.
- A premarket report described the earlier rise as a rebound after Friday’s decline and reported no company-specific catalyst.
- Major indexes are higher, but the supplied context does not support attributing the decline to broad-market direction; no trading-volume data was provided.